Search
Fluoroacetic acid F-18
go.drugbank.com/drugs/DB15202InvestigationalFluoroacetic acid F-18 is under investigation in clinical trial NCT01320787 (18-F-Fluoroacetate as PET Imaging Agent).
Synonyms: Fluoroacetic acid F-18Telaglenastat
go.drugbank.com/drugs/DB15232InvestigationalTelaglenastat is under investigation in clinical trial NCT02071862 (Study of the Glutaminase Inhibitor CB-839 in Solid Tumors).
Categories: Heterocyclic Compounds, 1-RingDihematoporphyrin ether
go.drugbank.com/drugs/DB15351InvestigationalDihematoporphyrin ether is under investigation in clinical trial NCT00118222 (High Light and Low Light Dose PDT in Glioma).
Synonyms: bis-1-(8-(1-hydroxyethyl)deuteroporphyrin-3-yl)ethyl etherCategories: Heterocyclic Compounds, 1-Ring, Heterocyclic Compounds with 4 or More RingsDihydrocapsiate
go.drugbank.com/drugs/DB15398InvestigationalDihydrocapsiate is under investigation in clinical trial NCT00999297 (Effect of 4-week Dihydrocapsiate Ingestion on Resting Metabolic Rate).
Recanaclotide
go.drugbank.com/drugs/DB15417InvestigationalRecanaclotide is under investigation in clinical trial NCT01712412 (Phase 2a Study of IW-9179 to Treat Functional Dyspepsia).
Ethyl butyrate
go.drugbank.com/drugs/DB15454ExperimentalEthyl butyrate is under investigation in clinical trial NCT03202342 (fMRI of Hypothalamic Responses to Taste, Temperature and Glucose).
Carbenoxolone
go.drugbank.com/drugs/DB02329ExperimentalIt is used for the treatment of digestive tract ulcers, especially in the stomach. Antidiuretic side effects are frequent, but otherwise the drug is low in toxicity. [PubChem]
Products: HERPESAN GEL 2%Thiostrepton
go.drugbank.com/drugs/DB11467InvestigationalVet approvedThiostrepton is a natural product of the ribosomally synthesized and post-translationally modified peptide class. … Thiostrepton is a natural cyclic oligopeptide antibiotic, derived from several strains of streptomycetes including Streptomyces azureus and Streptomyces laurentii.
Ulixertinib
go.drugbank.com/drugs/DB13930InvestigationalUlixertinib is a a novel, reversible, ATP-competitive ERK1/2 inhibitor with high potency and ERK1/2 selectivity [A31474]. … It is currently in clinical trials for the treatment of a wide range of tumors.
Categories: Heterocyclic Compounds, 1-RingOntuxizumab
go.drugbank.com/drugs/DB16270InvestigationalOntuxizumab is a humanized monoclonal antibody that targets endosialin or tumour endothelial marker 1 (TEM-1). … It is under investigation in clinical trial NCT01574716 (Sarcoma Study of Morab-004 Utilization: Research and Clinical Evaluation).